However, in contrast to oncogenic AP-1 activation in T-NHL, this process strictly depends on external induction of co-stimulatory pathways such as CD28 (ref. 57) through still ill-defined mechanisms. This evidence concerns the gene FOS and non-Hodgkin lymphoma.